Cardioprotection due to preconditioning correlates with increased ecto-5′-nucleotidase activity

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 1 39-1, 1996, Pages

  Minamino, Tetsuo ^a   Kitakaze, Masafumi ^b   Morioka, Toshikazu ^b   Node, Koichi ^b   Komamura, Kazuo ^b   Takeda, Hiroshi ^b   Inoue, Michitoshi ^b   Hori, Masatsugu ^b   Kamada, Takenobu ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Adenosine; Time window; ; methyleneadenosine 5 diphosphate

Indexed keywords

ECTO 5' NUCLEOTIDASE; ENZYME INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ACTIVATION; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ANIMALS; CYTOSOL; DOGS; FEMALE; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RECURRENCE; TIME FACTORS;

EID: 0030040195     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.1.h238     Document Type: Article

References (35)

1. Armstrong, S. C., and C. E. Ganote. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on metabolically inhibited and ischemic myocytes. J. Mol. Cell. Cardiol. 24: 869-884, 1992.
2. 1-adrenergic mechanism. Circ. Res. 73: 656-670, 1993.
3. Cohen, P. Signal integration at the level of protein kinases, protein phosphatases and their substances. In: Trends in Biochemical Science, edited by H. G. Purton. Cambridge, UK: Elsevier, 1992, p. 408-413.
4. Deutsch, E., M. Berger, W. G. Kussmaul, K. W. Hirshfeld, Jr., H. C. Herrmann, and W. Laskey. Adaptation in ischemia during percutaneous transmural coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 82: 2044-2051, 1990.
5. Ely, S. W., R. M. Mentzer, Jr., R. D. Lasely, B. K. Lee, and R. M. Berne. Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J. Thorac. Cardiovasc. Surg. 90: 549-556, 1985.
6. Finegan, B. A., A. S. Clanachan, C. S. Coulson, and G. D. Lopaschuk. Adenosine modification of energy substrate use in isolated hearts perfused with fatty acids. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1501-H1507, 1992.
7. Finegan, B. A., G. D. Lopaschuk, C. S. Coulson, and A. S. Clanachan. Adenosine alters glucose use during ischemia and reperfusion in isolated rat heart. Circulation 87: 900-908, 1993.
8. Fralix, T. A., E. Murphy, R. E. London, and C. Steenbergen. Protective effects of adenosine in the perfused rat heart: changes in metabolism and intracellular ion homeostasis. Am. J. Physiol. 264 (Cell Physiol. 33): C986-C994, 1993.
9. Gross, G. J., and J. A. Auchampach. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70: 223-233, 1992.
10. Hori, M., and M. Kitakaze. Adenosine, the heart, and coronary circulation. Hypertension Dallas 18: 565-574, 1991.
11. 1-padrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat myocardiocytes by activating protein kinase C. Circulation 91: 2226-2234, 1995.
12. 1-adrenoceptor activation mediates the infarct size limiting effect of ischemic preconditioning through augmentation of 5′-nucleotidase activity. J. Clin. Invest. 93: 2197-2205, 1994.
13. Kitakaze, M., M. Hori, T. Morioka, T. Minamino, S. Takashima, H. Sato, Y. Shinozaki, M. Chujo, H. Mori, M. Inoue, and T. Kamada. The infaret size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation 89: 1237-1246, 1994.
14. Kitakaze, M., M. Hori, S. Takashima, H. Sato, M. Inoue, and T. Kamada. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implication for myocardial salvage. Circulation. 87: 208-215, 1993.
15. 2 receptors prevents myocardial stunning (Abstract). Circulation 82, Suppl. III: 111-37, 1990.
16. Li, G. C., J. A. Vasquez, K. P. Gallagher, and B. R. Lucchesi. Myocardial protection with preconditioning. Circulation 82: 609-619, 1990.
17. 1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
18. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
19. Mitchell, M. B., X. Meng, L. Ao, J. M. Brown, A. H. Harken, and A. Bannerjee. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ. Res. 76: 73-81, 1995.
20. Mori, H., S. Haruyama, Y. Shinozaki, H. Okino, A. Iida, R. Takanashi, I. Sakura, W. Husseini, B. Payne, and J. I. E. Huffman. New nonradioactive microspheres and more sensitive X-ray fluorescence to measure regional blood flow. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1946-H1957, 1992.
21. Murphy, C. E., T. A. Fralix, R. E. London, and C. Steenbergen. Effects of adenosine antagonists on hexose uptake and preconditioning in perfused rat heart. Am. J. Physiol. 265 (Cell Physiol. 34): C1146-C1155, 1993.
22. Murry, C. E., R. B. Jennings, and K. A. Reimer. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
23. Murry, C. E., and V. J. Richard. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H796-H804, 1991.
24. Murry, C. E., V. J. Richard, K. A. Reimer, and R. B. Jennings. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res. 66: 913-931, 1990.
25. Okazaki, Y., K. Kodama, H. Sato, M. Kitakaze, A. Hirayama, M. Mishima, M. Hori, and M. Inoue. Attenuation of increased regional oxygen consumption during exercise as a major cause of warm-up phenomenon. J. Am. Coll. Cardiol. 21: 1597-1604, 1993.
26. Reibel, D. K., and M. J. Rovetto. Myocardial adenosine salvage rates and restoration of ATP content following ischemia. Am. J. Physiol. 237 (Heart Circ. Physiol. 6): H247-H252, 1979.
27. Savic, V., V. Stefanovic, N. Ardaillou, and R. Ardinou. Induction of ecto-5′-nucleotidase of rat cultured mesangial cells by interleukin-1 beta and tumor necrosis factor-alpha. Immunology 70: 321-326, 1990.
28. Smith, K., H. H. Varon, G. J. Race, D. L. Paulson, H. C. Urshel, and J. T. Mallams. Serum 5′-nucleotidase in patients with tumor in the liver. Cancer 19: 1281-1285, 1965.
29. Steenbergen, C., M. Perlman, R. E. London, and E. Murphy. Mechanisms of ischemic preconditioning. Ionic alterations, Circ. Res. 72: 112-125, 1993.
30. Toombs, C. F., D. S. McGee, W. E. Jonston, and J. V. Johansen. Myocardial protective effects of adenosine: infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 86: 986-994, 1992.
31. 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ. Res. 75: 576-585, 1994.
32. Van Winkle, D. M., G. L. Chien, R. A. Wolff, B. E. Soifer, K. Kuzume, and R. F. Davis. Cardioprotection provided by adenosine receptor activation is abolished by blockade of K-ATP channel. Am. J. Physiol. 266 (Heart Circ. Physiol. 351) H829-H839, 1994.
33. Van Wylen, D. G. L. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 89: 2283-2289, 1994.
34. Wolfe, C. L., R. E. Sievers, F. L. J. Visseren, and T. J. Donnelly. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 87: 881-892, 1993.
35. Zahler, S., B. F. Becker, P. Raschke, and E. Gerlach. Stimulation of endothelial adenosine A1 receptors enhances adhesion of neutrophils in intact guinea pig coronary system. Cardiovasc. Res. 28: 1366-1372, 1994.